Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
13.13
+1.24 (10.43%)
At close: May 8, 2025, 4:00 PM
13.13
0.00 (0.00%)
After-hours: May 8, 2025, 4:00 PM EDT
Bicara Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$29.67
Upside
+125.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Initiates $8 | Sell | Initiates | $8 | -39.07% | Apr 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $44 | Strong Buy | Maintains | $45 → $44 | +235.11% | Apr 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | -0.91% | Mar 13, 2025 |
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +136.10% | Feb 12, 2025 |
| Wedbush | Wedbush | Buy Initiates $31 | Buy | Initiates | $31 | +136.10% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +242.73% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +219.88% | Dec 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 8, 2024 |
| Stifel | Stifel | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +257.96% | Oct 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +166.57% | Oct 8, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 8, 2024 |